Sitemap
Pages
- Amanda Forys
- Commercialization & Analytics
- Contact Us
- Events
- Healthcare Policy & Access
- Home
- Insights
- Meet MKG
- Meet Our Team
- Our Expertise
- Our Work
- Pricing & Value Consulting
- Privacy Policy
- RWE & HEOR Strategy
- Sitemap
- Terms of Use
Insights
- Objection Handling: How Should Manufacturers Evolve to Meet the Clinical and Contracting Demands of Payers?
- Identifying the Market, Business and Reimbursement Potential for Cell Therapies
- Optimal Pricing Model Identification
- Understand Perceptions of Your Hub Program
- Developing a Comprehensive Launch Plan
- Magnolia’s Compendia Submission Helped Client Obtain Payer Coverage
- Patient Risk Assessments × Deep 6 AI
- Assessing the Implications of Financial Requirements on Commercial Copay Assistance Program
- Telling a Value Story
- Payer Intelligence to Gather Feedback and Understand Potential Coverage and Reimbursement of an AI CVD Technology
- Linking EMR With SDOH Data: Insights Across Disease Cohorts Presentation
- Linking EMR With SDOH Data: Insights Across Disease Cohorts
- Social Determinants of Health in a Real-World Adult HIV Population: ICD-10-CM and Consumer Linked Data Identification
- Payer Insights Survey: Gathering Early Perceptions of Health Plan Response to the Inflation Reduction Act of 2022
- Learnings from Linking Closed Claims Patient Cohorts with Consumer SDOH Data
- Gauging how healthcare payers and pharmaceutical manufacturers are reacting to the Inflation Reduction Act of 2022
- Gathering early perceptions of payer response to the Inflation Reduction Act of 2022
- Gathering early perceptions of payer response to the Inflation Reduction Act of 2022: Medicare Part D Redesign
- Enhancing Oncology Model (EOM) Fact Sheet
- Enhancing Oncology Model (EOM) White Paper: Perspectives from Oncology Practices and the Path Forward in Value-Based Care
- Developing strategic game plans in response to shifts in federal policy
- Launch planning in an ever-evolving policy and regulatory landscape
- Developing the appropriate regulatory strategy for a patient-centric, therapy-agnostic app
- Using payer and age mix as the basis for developing a go-to-market strategy for a prelaunch drug
- Providing program management support in the lead-up to NDA submission and launch
- Designing a coding gameplan for a soon-to-launch infused biologic
- Realigning the Hub
- Lining up support for a New Technology Add-on Payment in a rare-disease treatment
- FY24 Hospital Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital Prospective Payment System (LTCH) Proposed Rule
- Using published evidence and compendia to support expanded coverage for an off-label medication dosage
- Pricing an oral formulation for a bioequivalent COPD product
Case Studies
- Linking EMR With SDOH Data: Insights Across Disease Cohorts Presentation
- Linking EMR With SDOH Data: Insights Across Disease Cohorts
- Social Determinants of Health in a Real-World Adult HIV Population: ICD-10-CM and Consumer Linked Data Identification
- Learnings from Linking Closed Claims Patient Cohorts with Consumer SDOH Data
- Payer Insights Survey: Gathering Early Perceptions of Health Plan Response to the Inflation Reduction Act of 2022
- Gauging how healthcare payers and pharmaceutical manufacturers are reacting to the Inflation Reduction Act of 2022
- Gathering early perceptions of payer response to the Inflation Reduction Act of 2022
- Gathering early perceptions of payer response to the Inflation Reduction Act of 2022: Medicare Part D Redesign
- Enhancing Oncology Model (EOM) Fact Sheet
- Enhancing Oncology Model (EOM) White Paper: Perspectives from Oncology Practices and the Path Forward in Value-Based Care
- Developing strategic game plans in response to shifts in federal policy
- Launch planning in an ever-evolving policy and regulatory landscape
- Developing the appropriate regulatory strategy for a patient-centric, therapy-agnostic app
- Using payer and age mix as the basis for developing a go-to-market strategy for a prelaunch drug
- Providing program management support in the lead-up to NDA submission and launch
- Designing a coding gameplan for a soon-to-launch infused biologic
- Realigning the Hub
- Lining up support for a New Technology Add-on Payment in a rare-disease treatment
- FY24 Hospital Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital Prospective Payment System (LTCH) Proposed Rule
- Using published evidence and compendia to support expanded coverage for an off-label medication dosage
- Pricing an oral formulation for a bioequivalent COPD product
Team Members
- Herman Chen
- Ajay Keshava
- Amanda O’Hora
- Pamela Landsman-Blumberg
- Tracy Baroni Allmon
- Sean McGonigal
- Jessica Duchen
- Jennifer Ellis
- Martine Estchmaier
- Anna Hundt Golden
- Rebecca (Becky) Roman
- Rachel Besse
- Parker Edman
- Michael (Mike) Murphy
- Beni Turner
- Jason Collyer
- Charlotte Hanby
- Naseeb Chhina